These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Papillary microcarcinoma of the thyroid. Shaha AR; Tuttle RM; Shah JP J Surg Oncol; 2007 Jun; 95(7):532-3. PubMed ID: 17192917 [No Abstract] [Full Text] [Related]
6. Hürthle cell carcinoma: a clinicopathological study of thirteen cases. Ozlem Küçük N; Kulak H; Tokmak E; Tar P; Ibiş E; Aras G Nucl Med Commun; 2006 Apr; 27(4):377-9. PubMed ID: 16531925 [TBL] [Abstract][Full Text] [Related]
7. Contralateral papillary thyroid cancer at completion thyroidectomy has no impact on recurrence or survival after radioiodine treatment. Grigsby PW; Reddy RM; Moley JF; Hall BL Surgery; 2006 Dec; 140(6):1043-7; discussion 1047-9. PubMed ID: 17188155 [TBL] [Abstract][Full Text] [Related]
8. The treatment of papillary carcinoma of the thyroid occurring after irradiation. Crile G Surg Gynecol Obstet; 1980 Jun; 150(6):850-2. PubMed ID: 7376046 [No Abstract] [Full Text] [Related]
11. The role of radiotherapy and radioactive iodine in the treatment of thyroid cancer without metastases. Tubiana M; Charbord P; Cukersztein W; Sarrazin D; Fontaine F; Parmentier C Ann Radiol (Paris); 1977; 20(8):801-9. PubMed ID: 610552 [No Abstract] [Full Text] [Related]
12. Radioiodine therapy for papillary and follicular thyroid carcinoma. Klain M; Ricard M; Leboulleux S; Baudin E; Schlumberger M Eur J Nucl Med Mol Imaging; 2002 Aug; 29 Suppl 2():S479-85. PubMed ID: 12192549 [TBL] [Abstract][Full Text] [Related]
13. Thyroperoxidase: a tumor marker for post-therapeutic follow-up of differentiated thyroid carcinomas? Results of a time course study. Franke WG; Zöphel K; Wunderlich GR; Mat R; Kühne A; Schimming C; Kropp J; Bredow J Cancer Detect Prev; 2000; 24(6):524-30. PubMed ID: 11198265 [TBL] [Abstract][Full Text] [Related]
14. Role of radioiodine in management of thyroid cancer: experience with 70 cases. Afroz S; Ahmed K; Yasmeen S; Ahmed F; Nisa L Bangladesh Med Res Counc Bull; 1992 Dec; 18(2):68-71. PubMed ID: 1303083 [TBL] [Abstract][Full Text] [Related]
15. Radioiodine therapy in differentiated thyroid carcinoma. Salvatori M; Rufini V; Garganese MC; Di Giuda D Rays; 2000; 25(2):221-38. PubMed ID: 11370540 [TBL] [Abstract][Full Text] [Related]
16. Clinical outcome of patients with papillary thyroid carcinoma who have recurrence after initial radioactive iodine therapy. Vassilopoulou-Sellin R; Schultz PN; Haynie TP Cancer; 1996 Aug; 78(3):493-501. PubMed ID: 8697396 [TBL] [Abstract][Full Text] [Related]
17. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer]. Lind P; Igerc I; Kohlfürst S Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998 [TBL] [Abstract][Full Text] [Related]
18. [The medullary (C-cell) carcinoma of the thyroid. A therapeutic dilemma]. Schumann J; Hauk H; Leonhardi B Chirurg; 1977 Oct; 48(10):666-70. PubMed ID: 913180 [TBL] [Abstract][Full Text] [Related]
19. [Differentiated thyroid carcinoma in children and adolescents: therapeutic strategy according to clinic presentation]. Causeret S; Lifante JC; Borson-Chazot F; Varcus F; Berger N; Peix JL Ann Chir; 2004; 129(6-7):359-64. PubMed ID: 15297226 [TBL] [Abstract][Full Text] [Related]
20. Vocal cord paralysis following I-131 ablation of a postthyroidectomy remnant. Lee TC; Harbert JC; Dejter SW; Mariner DR; VanDam J J Nucl Med; 1985 Jan; 26(1):49-50. PubMed ID: 3965651 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]